Complete Consent

The proven, global eConsent platform

IQVIA Complete Consent is the user-friendly, flexible, and feature-rich electronic informed consent solution built to support diverse protocols at a global scale.

Deliver highly engaging compliant eConsent

Verified through more than 350 studies with over 400,000 participants and 10,000 sites, IQVIA Complete Consent meets the needs of all trial types.

eConsent helps sponsors achieve better outcomes across the entire study lifecycle, while delivering an enhanced experience for patients and more convenience for sites.

DEPLOY COMPLETE CONSENT AROUND THE WORLD WITH CONFIDENCE
IQVIA Complete Consent
Video Player is loading.
Current Time 0:00
Duration 1:53
Loaded: 8.73%
Stream Type LIVE
Remaining Time 1:53
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    IQVIA Complete Consent delivers unmatched value to all stakeholders

    Sponsors

    • Compliant data by reducing consent-related protocol deviations
    • Global delivery with configurable documents and multiple language support
    • Increase patient recruitment and retention to accelerate trial conduct
    • Deep experience in oncology, vaccines, cardiovascular, and more therapeutic areas
    • Consent reporting and analytics for study design and enrollment strategies

    Sites

    • Consenting workflows from the first document through amendments
    • Reduce administrative burden and errors compared to paper processes
    • Single sign-on and integrations to eliminate redundant data entry
    • Empower site staff to focus on patient experience and answer questions
    • Flexibility in document collections and version management

    Participants

    • Interactive multimedia features explain details of study participation
    • Make informed decisions about trial expectations, risks, and benefits
    • Review and sign digital consent forms on any internet enabled device
    • Accessible, configurable technology for pediatric, elderly, and impaired patients
    • Participants may highlight areas of the document for further discussion with the study physician

    Reduce protocol deviations

    In a review of nearly 100 trials across IQVIA that used eConsent, compared to paper, consent-related major and critical protocol deviations were reduced from an average of 14% to only 6%. This entailed a combination of electronic signature and print-to-sign modalities.

    Insight brief

    Deliver interactive, compliant remote consent

    The right remote consent solution provides participants with tools to understand the study and pose questions to site personnel, while minimizing disruptions to their daily lives. An eConsent solution should also empower study teams and sites to spend more time conducting the study by reducing the burden of administrative tasks such as addressing deviations.

    Insight brief

    IQVIA experts tailor eConsent for each study

    IQVIA Complete Consent supports all trial types and business models, from decentralized to traditional site-based trials, from standalone self-managed to full-service solutions with implementation services. We partner with sponsors at every step so you can deliver eConsent at sites around the world with confidence.

    ECONSENT BROCHURE

    Transform the eConsent experience

    Discover how IQVIA Complete Consent delivers an accessible solution to patients, operational efficiencies to sites, and a powerful platform to sponsors implementing eConsent flexibly and compliantly around the world.

    Related Solutions

    Contact Us